Abstract
Advances in positron emission tomography (PET) make it possible to measure the rate of chemical reactions within the human body. This makes it possible to identify disease at the molecular as well as the cellular level in living human beings. PET imaging is revolutionizing medicine by making it possible for the first time to measure in vivo chemistry, expressing the results in absolute units of metres, kilograms and seconds (the MKS system), rather than in relative terms, such as the percentage of the administered dose of radioiodine accumulated by the thyroid, or the amount of thallium-201 in one part of the myocardium compared to another. PET is bringing about a new way of looking at disease, by making it possible to define disease in terms of regional chemistry, measuring regional chemistry in normal persons to provide standards. Then diseases are defined as deviations from the norm by statistical analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bernardi, S., Trimble, M. R., Frackowiak, R. S. et al. (1983) An interictal study of partial epilepsy using positron emission tomography and the oxygen-15 inhalation technique. J. Neurol. Neurosurg. Psych., 46, 473–7.
Brunken, R., Tilisch, J., Schwaiger, M. et al. (1986) Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarcations: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation, 73, 951–63.
Camici, P., Araujo, L. I., Spinks, T., et al. (1986) Increased uptake of 18 F-fluorodeoxyglucose in post-ischemic myocardium of patients with exercise-induced angina. Circulation, 74, 81–8.
Chugani, H. T., Engel, J. Jr, Mazziotta, J. C. and Phelps, M. E. (1984) 18F-2-fluorodeoxyglucose positron emission topography in medically refractory childhood epilepsy. Neurol., 34, (Supply 1) 107.
Deanfield, J. E., Kensett, M., Wilson, R. A. (1984) Silent myocardial ischaemia due to mental stress. Lancet, i, 1001–5.
Deanfield, J. E., Shea, M., Ribiero, P. et al. (1984b) Transient ST-segment depression as a marker of myocardial ischemia during daily life, Am. J. Cardiol, 54, 1195–200.
Deanfield, J. E., Shea, M. J., Wilson, R. A. (1986) Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow. Am. J. Cardiol, 57, 1005–9.
Depresseux, J. C, Granck, G. and Sadzot, B. (1984) Regional cerebral blood flow and oxygen uptake rate in human focal epilepsy, in Current Problems in Epilepsy (eds M. Blady-Moulinier, D. H. Ingvar and B. S. Meldrum) pp. 76–81, John Libby, London.
Engel, J. Jr, Rausch, R., Lieb, J. P. et al. (1981) Correlation of criteria used for localizing epileptic foci in patients considered for surgical therapy of epilepsy. Ann. Neurol., 9, 215–24.
Engel, J. Jr, Kuhl, D. E., Phelps, M. E. and Mazziotta, J. C. (1982) Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG chantes. Ann. Neurol., 12, 510–17.
Engel, J. Jr, Kuhl, D. E., Phelps, M. E. and Crandall, P. H. (1982) Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann. Neurol., 12, 529–37.
Engel, J. Jr (1984) The use of PET scanning in epilepsy. Ann. Neurol., 15, (Suppl), 5180–5191.
Engel, J. Jr, Lubens, P., Kuhl, D. E. and Phelps, M. E. (1985) Local cerebral metabolic rate for glucose during petit mal absences. Ann. Neurol., 17, 121–28.
Frackowiak, R. S. F., Wise, R. J. (1983) Positron tomography in ischemic cardiovascular disease. Neurol. Clin., 1, 183–200.
Goldstein, R. A., Kirkeeide, R., Demer, L. et al. (1986) Assessment of coronary flow reserve with quantitative coronary arteriography. J. Nucl. Med., 27, 943.
Gould, K. L. (1978) Noninvasive assessment of coronary stenosis by myocardial perfusion imaging during pharmacological coronary vasodilation. I. Am. J. Cardiol, 41, 267–8.
Gould, K. L., Goldstein, R. A., Mullani, N. A. et al. (1986) Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J. Am. Coll. Cardiol., 775–89.
Grover-McKay, M., Schelbert, H. E., Schwaiger, M. et al. (1986) Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis. Circulation, 74, 281–92.
Gur, R. C, Sussman, N. M., Alavi, A. et al. (1982) Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Neurology, 32, 1191–4.
Jones, R. H., McEwan, P., Newam, G. E. et al. (1981) Accuracy of diagnosis of coronary artery disease by measurement of left ventricular function during rest and exercise. Circulation, 64, 586–601.
Kannel, W. B. and Abbott, R. D. (1984) Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N. Engl. J. Med., 311, 1114–47.
Kuhl, D. E., Engel, J. Jr, Phelps, M. E. and Selin, C. (1980) Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FOG and 15NH3. Ann. Neurol., 8, 348–60.
Kuhl, D. E., Engel, J. Jr and Phelps, M. E. (1983) Emission computed tomography in the study of human epilepsy. Res. Publ. Assoc. Res. Nerv. Ment. Dis., 61, 327–40.
Kuhl, D. E., Phelps, M. E., Markham, C. E. et al. (1983) Cerebral metabolism and atrophy in Huntington’s disease determined by FDG and computed tomographic scan. Ann. Neurol., 12, 425–34.
Kuhl, D. E., Metter, E. J., Riege, W. H. et al. (1983) Local cerebral glucose utilization in elderly patients with depression, multiple infarct dementia and Alzheimer’s disease. J. Cereb. Bid. Flow. Met., 3, (Suppl 1), 494–5.
Kuhl, D. E. (1984) Annual Oration 1982: Imaging local brain function with emission computed tomography. Radiology, 150, 625–31.
Kushner, M., Reivich, ML, Fieschi, C. et al (1987) Metabolic and clinical correlates of acute ischemic infarction. Neurology, 37 (7), 1103–10.
Lown, B. (1979) Sudden cardiac death: The major challenge confronting contemporary cardiology. Am.]. Cardiol, 43, 313–28.
Marshall, R. C, Tillisch, J. H., Phelps, M. E. et al (1987) Identification and differentiation of resting myocardial ischemia and infarction in man with position computed tomography; F-18 labelled fluoroctexyglucose and N-13 ammonia. Circulation, 67, 766–78.
Mathias, C. J., Broadack, J. W., Kilbourn, M. R. et al. Biodistribution and metabolism of 16-alpha-(18-F)-fluoro-17-beta-estradiol. J. Nucl. Med., 26, 127.
Mazziotta, J. C. and Engel, J. Jr (1984) The use and impact of PET scanning in epilepsy. Epilepsia, 25 (Suppl 2), s86-sl04.
Midwall, J., Ambrose, J., Pichard, A. (1982) Angina pectoris before and after my cardial infarction. Chest, 81, 681–6.
Mintun, M. A., Welch, M. J., Mathias, C. J. et al. (1987) Application of 16-alpha-(18-F) fluoro-17-beta estradiol for the assessment of estrogen receptors in human breast carcinoma. Society of Nuclear Medicine Annual Meeting Abstracts.
Muhr, C, Bergstrom, M., Lundberg, P. O. et al. (1986) Dopamine receptors in pituitary adenomas: PET visualization. JCAT, 10, 175–80.
Newmark, M. E., Theodore, W., DeLaPaz, R. et al. (1981) Positron emission tomography in refractory complex partial seizures. Ann. Neurol., 10, 73–4.
Ochs, R. E., Yamamoto, Y. L., Gloor, R. et al. (1984) Correlation between the PET measurement of glucose metabolism and oxygen utilization with focal epilepsy. Neurol., 34 (Suppl 1), 125.
Patronas, N. J., Di Chiro, G., Brooks, R. A. et al. (1982) Work in progress. 18-F-fluorodeoxyglucose and PET in the evaluation of radiation necrosis of the brain. Radiology, 144, 885–9.
Reunanen, A., Aromaa, A, Pyorala, K. (1983) Social Insurance Institution’s coronary heart disease study: Baseline data and 5-year mortality experience. Acta Med. Scand., Suppl 673, 67–81.
Schelbert, H. R., Henze, E., Phelps, M. E. and Kuhl, D. E. (1982) Assessment of regional myocardial ischemia by positron-emission computed tomography. Am. Heart J., 103, 588–97.
Schelbert, H. R., Phelps, M. E. and Shina, K. I. (1983) Imaging metabolism and biochemistry — a look at the heart. Am. Heart. J., 105 (3), 522–6.
Schelbert, H. R. (1986) Evaluation of ‘metabolic fingerprints’ of myocardial ischaemia Can. J. Cardiol, Suppl. A. 121A–30A.
Schwaiger, M., Brunken, R., Grover-McKay, M. et al. (1986) Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J. Am. Coll. Cardiol.8, 800–8.
Selwyn, A. P., Allan, R. M., L’Abbate, A. L. et al. (1982) Relation between regional myocardial uptake of rubi-dium-82 and perfusion: absolute reduction of cation uptake in ischemia. Am. J. Cardiol., 50, 112–21.
Selwyn, A. P., Shea, M., Deanfield, J. et al. (1985) The character of transient myocardial ischemia: Clinical studies and progress using positron emission tomography. Inter. J. Card. Imag., 1, 61–72.
Sperling, M. R., Engel, J. Jr, Bradley, W. and Wilson, G. (1985) MRI, PET, and CT in complex partial epilepsy. Epilepsia, 26, 534–5.
Szelies, B., Herholz, K., Heiss, W. D. et al. (1983) Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: Demonstration by positron emission tomography. J. Comput. Assist. Tomogr., 7, 945–53.
Tamaki, N., Yonekura, Y., Senda, M. et al. (1985) Myocardial positron computed tomography with 13N-ammonia at rest and during exercise. Eur. J. Nucl. Med.1, 246–51.
Theodore, W. H., Newmark, M. E., Sato, S. et al. (1983) Fluorodeoxyglucose positron emission computed tomography in refractory complex partial seizures. Ann. Neurol., 13, 419–28.
Theodore, W. H., Brooks, R., Sata, S. et al. (1984) The role of positron emission tomography in the evaluation of seizure disorders. Ann. Neurol., 15 (Suppl), S176–9.
Theodore, W. H., Brooks, R., Margolin, R. et al. (1985) Positron emission tomography in generalized seizures. Neurol., 35, 684–90.
Theodore, W. H., Dorwart, R., Holmes, M. et al. (1986) Neuroimaging in refractory partial seizures. Comparison of PET, CT, and MRI. Neurol., 36, 60–4.
Tillisch, J., Brunken, R., Marshall, R. et al. (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N. Engl. J. Med., 314, 884–8.
Wagner, H. N. (1986) Chemical neurotransmission in man. Curr. Cone. Diagn. Nucl. Med., 3, 14–18.
Yano, Y., Budinger, T. E., Chiang, G. et al. (1979) Evaluation and application of alumina-based Rb-82 generators charged with high levels of Sr-82/85. J. Nucl.Med., 20, 961–6.
Yano, Y., Cahoon, J. L. and Budinger, T. F. (1981) A precision flow-controlled Rb-82 generator for bolus or constant-infusion studies of the heart and brain. J. Nucl. Med., 22, 1006–10.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Wagner, H.N. (1991). Clinical applications of positron emission tomography. In: Maisey, M.N., Britton, K.E., Gilday, D.L. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3358-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3358-4_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-27900-3
Online ISBN: 978-1-4899-3358-4
eBook Packages: Springer Book Archive